Table 4 Prevalence of cervical and oral HPV infection according to the HIV-related parameters
Variables | HPV+ (N = 56) | OR (CI) | P | Cervical HPV+ (N = 51) | OR (CI) | P | Oral HPV+ (N = 11) | OR (CI) | P |
|---|---|---|---|---|---|---|---|---|---|
N (%) | N (%) | N (%) | |||||||
Documented HIV infection (years) | |||||||||
< 5 | 39/73 (53.4) | 1.68 (0.79–3.60) | 0.24 | 36/73 (49.3) | 1.75 (0.81–3.71) | 0.18 | 7/73 (9.6) | 1.00 (0.28–3.23) | > 0.99 |
5–10 | 17/42 (40.5) | 1 | – | 15/42 (35.7) | 1 | 4/42 (9.5) | 1 | ||
> 10 | 0/0 (0) | – | – | – | – | – | – | – | |
Compliance to HAART | |||||||||
Yes | 42/93 (45.2) | 0.46 (0.18–1.17) | 0.15 | 39/93 (41.9) | 0.60 (0.22–1.50) | 0.34 | 9/93 (9.7) | 1.07 (0.23–5.25) | > 0.99 |
No | 14/22 (66.6) | 1 | – | 12/22 (54.5) | 1 | 2/22 (9.1) | 1 | ||
Most recent CD4 (cells/mm3) | |||||||||
< 200 | 3/3 (100) | – | – | 3/3 (100) | – | – | 0/3 (0) | – | – |
200–350 | 9/17 (52.9) | 1.30 (0.47–3.78) | 0.79 | 8/17 (47.1) | 1.22 (0.41–3.34) | 0.79 | 2/17 (11.8) | 1.27 (0.25–6.01) | 0.67 |
> 350 | 44/95 (46.3) | 1 | – | 40/95 (42.1) | 1 | 9/95 (9.5) | 1 | ||
Most recent viral load | |||||||||
Undetectable | 44/99 (44.4) | 1 | – | 39/99 (39.4) | 1 | 11/99 (11.1) | 1 | – | |
Detectable | 12/16 (75.0) | 3.75 (1.22–11.10) | 0.03 | 12/16 (75.0) | 4.61 (1.50–13.66) | 0.01 | 0/16 (0) | – | |